Galectin Therapeutics
GALT
#9131
Rank
โ‚ฌ73.35 M
Marketcap
1,16ย โ‚ฌ
Share price
-7.04%
Change (1 day)
-64.41%
Change (1 year)

EPS for Galectin Therapeutics (GALT)

EPS in 2023 (TTM): -0,62ย โ‚ฌ

According to Galectin Therapeutics's latest financial reports the company's current EPS (TTM) is -0,58ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -0,57ย โ‚ฌ a decrease over its 2021 EPS that were of -0,46ย โ‚ฌ.

EPS history for Galectin Therapeutics from 2002 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-0,62ย โ‚ฌ8.88%
2022-0,57ย โ‚ฌ25%
2021-0,46ย โ‚ฌ30%
2020-0,35ย โ‚ฌ-6.98%
2019-0,38ย โ‚ฌ13.16%
2018-0,33ย โ‚ฌ-22.45%
2017-0,43ย โ‚ฌ-35.53%
2016-0,67ย โ‚ฌ-13.64%
2015-0,77ย โ‚ฌ11.39%
2014-0,69ย โ‚ฌ-39.69%
2013-1,15ย โ‚ฌ81.94%
2012-0,63ย โ‚ฌ-32.08%
2011-0,93ย โ‚ฌ7.07%
2010-0,87ย โ‚ฌ-17.5%
2009-1,06ย โ‚ฌ150%
2008-0,42ย โ‚ฌ-68%
2007-1,32ย โ‚ฌ127.27%
2006-0,58ย โ‚ฌ-52.17%
2005-1,21ย โ‚ฌ-20.69%
2004-1,53ย โ‚ฌ52.63%
2003-1,00ย โ‚ฌ-13.64%
2002-1,16ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-11,28ย โ‚ฌ 1,842.42%๐Ÿ‡บ๐Ÿ‡ธ USA
-0,17ย โ‚ฌ-71.21%๐Ÿ‡บ๐Ÿ‡ธ USA